Meet Karl W. Smith

Karl develops mass spectrometry methods, particularly imaging and spatial approaches, to investigate diseases and conditions of clinical interest. His group examines molecular changes at scales ranging from whole organs to individual cells, seeking insights into disease processes and potential opportunities for diagnosis and treatment.

“The contribution of analytical science to medicine and the life sciences excites me most,” he says. Integrating multiomics with rapidly advancing analytical technologies could transform how therapeutic targets and biomarkers are identified, as well as the speed and precision with which diseases are diagnosed and treated. “In biomedical research, time can be a crucial factor, and I believe analytical science is increasingly well positioned to help us tackle that challenge.”

AI presents both promise and risk. “It has enormous potential to combine and integrate vast datasets, reveal previously hidden relationships, and enable deeper biological predictions,” Karl says. “I do, however, worry that its impact may become harmful when the analytical techniques used to gain this information are not fully studied or are overlooked in the pursuit of faster results. As data becomes increasingly accessible, it must still be challenged with rigor by trained experts.”

Karl’s family has given his research a strong personal motivation. “When family members are affected by things you feel like you only read about in the news, it can drive your ambition to add a little piece to the larger puzzle,” he says.

Crime thrillers have also influenced how he works: “Sometimes you must play a detective role in science and pick up on little details that other people may overlook.”